Genome-wide association studies (GWASs), combined with fine-mapping, have identified 196 independent signals associated with breast cancer risk. Deciphering the functional basis of these associations can inform our understanding of the biology and etiology of breast cancer. Decoding GWAS risk associations is challenging due to linkage disequilibrium between variants and because most variants map to non-coding regions, influencing breast cancer risk via cis-regulatory mechanisms that modulate the expression of target genes. To prioritize variants with allele-specific regulatory activity at breast cancer risk loci, we carried out a lentivirus-based massively parallel reporter assay (lentiMPRA) to screen 5,116 credible causal variants (CCVs) across these signals. We identified 709 variants mapping to 140 risk regions that are associated with significant variation between reference (REF) and alternative (ALT) alleles. A follow-up investigation at 14q32.11 revealed that rs7153397 may influence breast cancer risk through expression of CCDC88C, which in turn could impact prognosis. These findings provide a prioritized set of functional variants for downstream analyses, advancing our understanding of breast cancer risk mechanisms.
No takes yet. Share an insight, caveat, or question.
Mackie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: